FATE
Fate Therapeutics, Inc. · Healthcare
CFO Edward J Dulac III sold $153K of Fate Therapeutics, Inc.
Sold$153,051
$29.81Price
5,135Shares
−4%Stake
What FATE did after the filing
- The stock from Fri, Aug 19 close, $29.03
- −21.9%
- S&P 500, same days
- −12.8%
Measured over 30 trading days, to the Oct 3 close.
Traded Thu, Aug 18. Filed Fri, Aug 19, 2:58 PM ET, during the session. Returns use the Aug 19 close and the Oct 3 close. Not investment advice.